Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
- PMID: 23407769
- PMCID: PMC3564172
- DOI: 10.5455/aim.2011.19.235-240
Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Abstract
As we approach the end of 2011 it is clear that the next few years are going to be dominated by the application of new high throughput genetic screening techniques, capable of screening the entire exome or indeed genome. Understanding the data generated by these techniques will require new and equally sophisticated analysis of large and complex datasets, using a systems biology approach with deeper phenotyping and advanced modelling techniques that have the flexibility for continuous update, refinement with discovery of new knowledge. Exciting new developments that may also transform cardiomyopathy research include those of infrastructure and organisation (multi-centre collaborations) and spin-offs from the field of regenerative medicine research. For clinical researchers that translate this information to the clinic the focus will however remain the same; namely improvement of quality and quantity of life.
Keywords: cardiomyopathies; clinical cardiology..
References
-
- Hagege AA, Caudron E, Damy T, et al. Screening patients with hypertrophic cardiomyopathy for fabry disease using a filter-paper test: the focus study. Heart. 2011;97:131–6. - PubMed
-
- Olivotto I, Maron BJ, Appelbaum E, et al. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010;106:261–7. - PubMed
-
- O’Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56:867–74. - PubMed
-
- Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56:875–87. - PubMed
-
- Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials